Sutter Health’s Advanced Illness Management Program Wins HQI Vanguard Award
Top honors for unique program in home health patient safety, quality improvement
Fairfield, Calif.— Sutter Health’s Advanced Illness Management (AIM) program won the Hospital Quality Institute’s (HQI) Vanguard Award—a remarkable feat for a program that launched as a small pilot in 2009 with a visionary approach to that part of life between relative wellness and hospice care.
“Sutter Health’s AIM program application was chosen from a field of 53 qualified applications, reflecting a remarkable breadth and depth of quality work occurring in our state,” HQI President/CEO Julianne Morath said. “This is a successful global solution to a problem that affects every family sooner or later.” Read More about HQI Vanguard Award for Sutter Health’s AIM Program
Sutter Health hospitals, which have among the lowest cesarean section (C-section) rates in California, were recognized by the California Health and Human Services Department for reducing cesarean births for first-time moms with low-risk pregnancies. Eleven Sutter hospitals were named to the state’s 2016 Hospital C-section Honor Roll.
California Health and Human Services Secretary Diana Dooley announced achievement awards this week on behalf of Smart Care California, a coalition of public and private health care purchasers that collectively cover 16 million people statewide—or 40 percent of all Californians.
The following Sutter Health hospitals were named to the 2016 Hospital C-section Honor Roll:
• Alta Bates Summit Medical Center, Berkeley
• California Pacific Medical Center, San Francisco
• Eden Medical Center, Castro Valley
• Sutter Davis Hospital
• Sutter Delta Medical Center, Antioch
• Sutter Lakeside Hospital, Lakeport
• Sutter Maternity & Surgery Center of Santa Cruz
• Sutter Santa Rosa Regional Hospital
• Sutter Medical Center, Sacramento
• Sutter Roseville Medical Center
• Sutter Solano Medical Center, Vallejo
Sutter Health is among the first healthcare networks to partner with Onduo—a joint venture between Verily Life Sciences LLC, (formerly Google Life Sciences) and Sanofi—to support and simplify care for those with type 2 diabetes.
“This collaboration with Onduo further advances our work to develop engaging and incredibly personal care options for those with type 2 diabetes—and for their families—so they may live their very best lives,” said Chris Waugh, Sutter Health’s chief innovation officer. “Because our integrated network focuses on Northern California, where we care for one of the most diverse populations in the world, we offer partners like Onduo the unique opportunity to work with us to test treatments and tools in various care settings that can influence the care for people of all races and ethnicities.” Read More about Sutter Health Helps Develop Comprehensive Diabetes Management Platform
The Center for Disease Control (CDC) has tapped Sutter Health sepsis experts Sean Townsend, M.D., and Mary Ann Barnes-Daly, M.S., R.N., D.C., to lead a webinar on recognizing the early warning signs of sepsis. Sepsis, a life-threatening syndrome caused by the body’s overwhelming and life-threatening response to infection, is the number one cause of death nationwide for patients who die in the hospital. In the United States, more than 750,000 patients develop sepsis each year, and about 40 percent die from it.
CDC’s invitation to present the webinar acknowledges Sutter Health’s leadership in sepsis education, treatment and prevention, said Dr. Townsend, vice president of quality and safety at Sutter Health’s California Pacific Medical Center and physician lead for Sutter’s Sepsis Initiative.
“Through our Sepsis Initiative, Sutter Health has earned a national reputation leading best practices. Our work is closely tied to CMS’ new core measure for sepsis, known as SEP-1, assessing performance of hospitals across the country,” said Dr. Townsend. Dr. Townsend and other national experts collaborated on the drafting of the core measure for CMS and are responsible for its maintenance.
Four hospitals within Sutter Health’s not-for-profit network achieved recognition today as among the best hospitals in California for 2016-17 by U.S. News & World Report. The annual rankings rate top hospitals in the state and in major metropolitan regions, as well as top hospitals according to their performance across 25 specialties, procedures and conditions
Sutter Health hospitals recognized among the top 50 in the state and top 10 in their metro area include:
San Francisco metro area
Sacramento metro area
In addition, Sutter Medical Center, Sacramento, received “high performer” recognition in eight adult procedures/conditions, California Pacific Medical Center received “high performer” in five adult procedures/conditions, and both Sutter Roseville Medical Center and Mills-Peninsula Health Services received “high performer” recognition in four adult procedures/conditions.
“Rankings like these from U.S. News & World Report honor our network’s doctors, nurses, clinicians and employees who dedicate themselves daily to deliver high-quality, compassionate care across Northern California,” said Stephen Lockhart, M.D., Ph.D., chief medical officer for Sutter Health. “This recognition validates our ongoing commitment to improving quality and patient safety for our patients.”
“U.S. News evaluates nearly 5,000 hospitals nationwide,” said Ben Harder, chief of health analysis at U.S. News. “A hospital that emerged from our analysis as one of the best has much to be proud of.”
The U.S. News & World Report Best Hospitals survey ranked hospitals according to reputation, mortality, patient safety and other areas, including nurse staffing and technology.
For more information and complete rankings, visit U.S. News & World Report.
Sutter Health advances cardiovascular service by offering first-of-its-kind fully dissolving heart stent in Bay Area and Sacramento
Recently approved by FDA, Absorb bioresorbable vascular scaffold opens clogged arteries to restore blood flow, then gradually dissolves in the body
Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.
Sailesh Shah, M.D., an interventional cardiologist at Sutter Medical Center and David Daniels, M.D., an interventional cardiologist at Mills-Peninsula will implant patients with the world’s first FDA-approved dissolving heart stent.
The Absorb bioresorbable vascular scaffold is a major advance in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide despite decades of therapeutic advances.
While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in about three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants.
“This is the first real game-changer in coronary stents since 2003, when drug-coated metal stents were developed, helping to reduce risk of renarrowing of the arteries,” Dr. Daniels explained. “With dissolving stents you have the best of both worlds: you have the benefit of using a less invasive procedure than open heart surgery, and then the stent disappears, leaving no metal behind to restrict motion of the blood vessels.” Read More about Sutter Health advances cardiovascular service by offering first-of-its-kind fully dissolving heart stent in Bay Area and Sacramento